Table 2 of Simpson, Mol Vis 2011; 17:2649-2654.
Eye ID |
CVI at baseline (Mean±SD) |
CVI after treatment (Mean±SD) |
% change |
---|---|---|---|
Untreated | |||
246 OD | SCAR | SCAR | SCAR |
246 OS | 0.76±0.13 | SCAR | SCAR |
247 OD | 0.44±0.06 | SCAR | SCAR |
247 OS | 0.41±0.15 | 1.77±0.52 | 336 |
275 OD | 0.25±0.06 | 0.40±0.07 | 61 |
275 OS | 0.24±0.03 | 0.93±0.18 | 283 |
156 OD | SCAR | SCAR | SCAR |
156 OS | 3.48±0.32 | 3.92±0.59 | 12 |
277 OD | 0.46±0.26 | 0.78±0.45 | 67 |
277 OS | 0.53±0.27 | 0.67±0.39 | 25 |
Mean CVI | 0.82 | 1.41 | 173% |
Cysteamine treated | |||
276 OD | 0.38±0.13 | 0.41±0.17 | 9 |
276 OS | 0.77±0.40 | 0.60±0.19 | -21 |
278 OD | 0.43±0.09 | 0.49±0.08 | 16 |
278 OS | 0.48±0.01 | 0.37±0.17 | -22 |
279 OD | 0.25±0.15 | 0.60±0.13 | 137 |
279 OS | 0.17±0.11 | 0.28±0.13 | 65 |
249 OS | 0.82±0.26 | 0.73±0.01 | -10 |
249 OD | 2.45±0.53 | 1.13±0.55 | -53 |
245 OD | 0.55±0.17 | 2.87±2.32 | 416 |
245 OS | SCAR | SCAR | SCAR |
Mean CVI | 0.70 | 0.83 | 15% |